Psychosocial predictors of autologous bone marrow transplant patients’ functioning: indications for early intervention  by Lanza Hurley, C. et al.
demonstrated an inverse correlation between platelet count and
anti-GPIIb/IIIa antibody-producing B cell frequency. Thrombo-
cytopenia mediated by anti-platelet antibodies should be included
into differential diagnosis for prolonged thrombocytopenia after
allo-HSCT.
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FEF25-75% AS A SPIROMETRIC VARIABLE IN PULMONARY FUNCTION
TESTING (PFT) IS PREDICTIVE FOR THE DIAGNOSIS OF OBLITERATIVE
BRONCHIOLITIS (OB) FOLLOWING MYELOABLATIVE ALLOGENEIC HE-
MATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Burgos-Fuster, L.M., Koyama, T., Milestone, A., Mineishi, S., Jagasia,
M., Vusirikala, M., Goodman, S., Schuening, F., Greer, J.P., Chinra-
tanalab, W., Brandt, S., Ruffner, K., Morgan, D.S., Stein, R.S.,
Kassim, A.A. Vanderbilt University Medical Center, Nashville, TN;
Veterans Affairs Medical Center, Nasville, TN
Introduction: Following allogeneic HSCT, a major cause of
obstruction is OB (frequency, 8-33%). Diagnosis is histologic, but
often presumptive, based on clinical features, radiographic and
PFT changes showing obstruction, hyperinﬂation and gas trap-
ping. OB is associated with chronic, but not acute graft-versus-host
disease (cGVHD/aGVHD). A 5% decline in percent predicted
forced expiratory volume in 1 second (FEV1), FEV1/FVC (forced
vital capacity)  0.7 or 10% fractional drop from previous best
PFT was suggestive of OB in previous studies. It is yet to be
deﬁned which spirometric measurement is most suggestive for the
presence of OB. Forced expiratory ﬂow rates (FEF25-75%), with
30% decline from baseline was found to be more sensitive than
FEV1 in diagnosing OB following single lung transplant [Nathan,
et al, 2003 J Heart and Lung Transplantation 22(4): 427]. FEF25-
75% has never been evaluated following allogeneic HSCT. Meth-
ods: We retrospectively reviewed PFT data on 48 adult patients
undergoing HSCT from 1998-2003, who survived for at least 12
months and had pre and post-transplant PFT within 1-year of
HSCT. Median age was 42 years (range, 20-57), and 54% were
male. Forty-seven patients had malignant hematologic disorders.
The conditioning regimen was TBI-based in 34 (73%) patients,
and 13 received chemotherapy only. Marrow and peripheral blood
stem cells were used in 22 and 26 patients respectively. Results:
Incidence of aGVHD was 52%, (gradeI-II/III-IV: 88%/12%),
12% of patients had cGVHD (limited/extensive: 69%/13%). Ten
patients (21%) had a diagnosis of OB (8-histologicaly, 2-based on
signs and symptoms). Spirometric measurements considered as
predictor variables included diffusion capacity for carbon monox-
ide (DLCO), FEV1, total lung capacity (TLC), FEF 25-75%.
There was no signiﬁcant association between diagnosis of OB and
age, GVHD, stem cell source, preparatory regimen, TLC or
DLCO. A backward elimination model building procedure for a
logistic regression identiﬁed FEF25-75% as the sole signiﬁcant
explanatory variable. This model suggests that with a 40% decrease
or more in FEF 25-75% compared to pre-transplant value, the
estimated probability of the diagnosis of OB would be 50% or
higher. Conclusion: A decrease in FEF 25-75% of  of 40%, in
the absence of other non-infectious pulmonary complications, was
highly suggestive in allogeneic HSCT patients for the diagnosis of
OB. We plan to evaluate our ﬁndings in a prospective study.
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PSYCHOSOCIAL PREDICTORS OF AUTOLOGOUS BONE MARROW
TRANSPLANT PATIENTS’ FUNCTIONING: INDICATIONS FOR EARLY IN-
TERVENTION
Lanza Hurley, C.1, Mumby, P.B.2, Di Iorio, S.2, Stiff, P.J.2 1. Loyola
University Chicago, Chicago, IL; 2. Loyola University Medical Center,
Maywood, IL
Compared to mixed oncology samples, estimates of emotional
distress are considered to be higher for patients treated by bone
marrow transplant (BMT). This increased risk has been met by
limited research investigating psychosocial predictors of BMT psy-
chological and physical sequelae. Such analysis may serve to better
inform bone marrow treatment centers in identiﬁcation of patients
at risk for transplant-related psychological and physical morbidity.
Data from 210 consecutive adult cancer patients who underwent
autologous BMT at a large Midwestern cancer center were uti-
lized. There were 73 males and 137 females (mean age  48.25).
Prior to transplant, patients completed a BMT clinic questionnaire
and the Symptom-Checklist 90-Revised (SCL-90-R). Stepwise
multiple regression analyses were performed using the depression
subscale of the SCL-90-R, coping, and total social support (i.e.,
structural and perceived) as dependent variables. Age and total days
from diagnosis to treatment were controlled. Gender predicted
depressive symptomatology (beta  .216, t  2.187, p  .03)
and total social support (beta  .206, t  2.084, p  .039), with
males endorsing more depressive symptoms than females and fe-
males listing more structural support than males. Marital status
predicted social support speciﬁc to BMT (beta  .368, t 
4.538, p  .001) with married patients reporting fewer supports
through BMT than their unmarried counterparts. Females re-
ported larger support networks than males. Previous psychological
treatment predicted depressive symptomatology (beta  6.165, t 
2.874, p  .005) and improved coping (beta  .493, t  3.766,
p  .001). That married persons mainly rely upon spouses for
support may have important caregiver respite implications. In
addition, psychotherapy may improve patients’ conﬁdence in their
ability to cope with BMT despite increased levels of depression
prior to BMT. These ﬁndings suggest early psychological inter-
ventions for patients undergoing BMT may improve coping re-
sources for dealing with the stress of the process. Further analyses
will investigate whether these psychosocial factors predict BMT-
related psychological and physical morbidity.
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PROSPECTIVE STUDY OF MAJOR SALIVARY GLANDS IN PATIENTS SUB-
MITTED TO BONE MARROW TRANSPLANTATION-PRELIMINARY RE-
SULTS
Coracin, F.L.1, Camargo, E.E.2, Vigorito, A.C.1, Gasparetto, P.F.1,
Peterson, D.E.3, Correa, M.E.P.1, De Souza, C.A.1 1. Hematology and
Blood Transfusion Center-State University of Campinas-UNICAMP,
Campinas, Sa˜o Paulo, Brazil; 2. Division of Nuclear Medicine-State
University of Campinas-UNICAMP, Campinas, Sa˜o Paulo, Brazil; 3.
School of Dental Medicine-University of Connecticut, Farmington, CT
Salivary gland involvement in chronic GVHD (cGVHD) is in-
dicated by increased dryness of the oral cavity, abnormalities in the
saliva and histopathological changes in labial minor salivary glands.
Salivary changes leading to 45-60% of hyposalivation have been
reported in cGVHD in both and human studies. Fibrosis and
inﬂammatory inﬁltration were the mostly important histopatho-
logical changes observed in oral cGVHD minor salivary glands
biopsies. The aim of this study was to evaluate prospectively the
side effects of the conditioning regimen used for allogeneic BMT
on major salivary gland using scintigraphy with Gallium-67 and
technetium-99m-pertechnetate. This is an ongoing study per-
formed in the University Hospital of State University of Campi-
nas–Brazil. Between March 2002 until July 2003, ﬁfteen Chronic
Myeloid Leukemia (CML) and three Severe Aplastic Anemia
(SAA) patients submitted to conventional allogeneic BMT were
enrolled. Ten of them are female and 8 are male and the median
age of this group was 39 yo (31-55 years). Conditioning regimen
and GVHD prophylaxis used following Institutional protocols.
Scintigraphic exams was performed at Division of Nuclear Medi-
cine, using 10mCi of Technetium-99m pertechnetate and 3mCi of
Gallium-67, intravenously. Gallium-67 images were done after 48
hours of intravenous injection. Gallium-67 and Technetium data
are summarized in Table 1 and Table 2, respectively. These data
are preliminary. Scintigraphy showed an increase of inﬂammatory
reaction and a functional deﬁcit in major salivary glands after
BMT. Salivary glands dysfunction maybe due to cGVHD or side-
effect related to high dose chemotherapy. It is not clear in the
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